Lentiviral-mediated gene transfer – a patent review

Bibliography

• Aiuti A, Slavin S, Aker M, et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 2002;296(5577):2410-3
   PubMed Web of Science ®Google Scholar
• Hawley RG, Lieu FH, Fong AZ, et al. Retroviral vectors for production of interleukin-12 in the bone marrow to induce a graft-versus-leukemia effect. Annals of the New York Academy of Sciences. 1996;795:341-5
   Google Scholar
• Miller AD. Retroviral vectors. Curr Top Microbiol Immunol 1992;158:1-24
   PubMed Web of Science ®Google Scholar
• Miller AD, Miller DG, Garcia JV, Lynch CM. Use of retroviral vectors for gene transfer and expression. Methods Enzymology 1993;217:581-99
   PubMed Web of Science ®Google Scholar
• Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol cell biol 1990;10(8):4239-42
   PubMed Web of Science ®Google Scholar
• Roe T, Reynolds TC, Yu G, Brown PO. Integration of murine leukemia virus DNA depends on mitosis. EMBO J 1993;12(5):2099-108
   PubMed Web of Science ®Google Scholar
• Nienhuis AW, Dunbar CE, Sorrentino BP. Genotoxicity of retroviral integration in hematopoietic cells. Mol Ther 2006;13(6):1031-49
   PubMed Web of Science ®Google Scholar
• Lewis P, Hensel M, Emerman M. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J 1992;11(8):3053-8
   PubMed Web of Science ®Google Scholar
• Lewis PF, Emerman M. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 1994;68(1):510-6
   PubMed Web of Science ®Google Scholar
• Kinoshita S, Chen BK, Kaneshima H, Nolan GP. Host control of HIV-1 parasitism in T cells by the nuclear factor of activated T cells. Cell 1998;95(5):595-604
   PubMedGoogle Scholar
• Steffens CM, Managlia EZ, Landay A, Al-Harthi L. Interleukin-7-treated naive T cells can be productively infected by T-cell-adapted and primary isolates of human immunodeficiency virus 1. Blood 2002;99(9):3310-8
   PubMedGoogle Scholar
• Cavalieri S, Cazzaniga S, Geuna M, et al. Human T lymphocytes transduced by lentiviral vectors in the absence of TCR activation maintain an intact immune competence. Blood 2003;102(2):497-505
   PubMed Web of Science ®Google Scholar
• Costello E, Munoz M, Buetti E, et al. Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors. Gene Ther 2000;7(7):596-604
   PubMed Web of Science ®Google Scholar
• Dardalhon V, Jaleco S, Kinet S, et al. IL-7 differentially regulates cell cycle progression and HIV-1-based vector infection in neonatal and adult CD4+ T cells. Proc Natl Acad Sci USA 2001;98(16):9277-82
   PubMedGoogle Scholar
• Ducrey-Rundquist O, Guyader M, Trono D. Modalities of interleukin-7-induced human immunodeficiency virus permissiveness in quiescent T lymphocytes. J Virol 2002;76(18):9103-11
   PubMedGoogle Scholar
• Manganini M, Serafini M, Bambacioni F, et al. A human immunodeficiency virus type 1 pol gene-derived sequence (cPPT/CTS) increases the efficiency of transduction of human nondividing monocytes and T lymphocytes by lentiviral vectors. Hum Gene Ther 2002;13(15):1793-807
   PubMedGoogle Scholar
• Sandrin V, Boson B, Salmon P, et al. Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates. Blood 2002;100(3):823-32
   PubMed Web of Science ®Google Scholar
• Unutmaz D, KewalRamani VN, Marmon S, Littman DR. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J Exp Med 1999;189(11):1735-46
   PubMed Web of Science ®Google Scholar
• Verhoeyen E, Dardalhon V, Ducrey-Rundquist O, et al. IL-7 surface-engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytes. Blood 2003;101(6):2167-74
   PubMed Web of Science ®Google Scholar
• Verhoeyen E, Wiznerowicz M, Olivier D, et al. Novel lentiviral vectors displaying “early-acting cytokines” selectively promote survival and transduction of NOD/SCID repopulating human hematopoietic stem cells. Blood 2005;106(10):3386-95
   PubMedGoogle Scholar
• Selden C, Mellor N, Rees M, et al. Growth factors improve gene expression after lentiviral transduction in human adult and fetal hepatocytes. J Gene Med 2007;9(2):67-76
   PubMedGoogle Scholar
• Picanco-Castro V, Fontes AM, Heinz S, et al. The chimeric cytokine Hyper-IL-6 enhances the efficiency of lentiviral gene transfer in hepatocytes both in vitro and in vivo. Biotechnol Lett 2008;30(2):215-20
   PubMedGoogle Scholar
• Barrette S, Douglas JL, Seidel NE, Bodine DM. Lentivirus-based vectors transduce mouse hematopoietic stem cells with similar efficiency to moloney murine leukemia virus-based vectors. Blood 2000;96(10):3385-91
   PubMedGoogle Scholar
• Korin YD, Zack JA. Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J Virol 1998;72(4):3161-8
   PubMedGoogle Scholar
• Case SS, Price MA, Jordan CT, et al. Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors. Proc Natl Acad Sci USA 1999;96(6):2988-93
   PubMed Web of Science ®Google Scholar
• Follenzi A, Santambrogio L, Annoni A. Immune responses to lentiviral vectors. Curr Gene Ther 2007;7(5):306-15
   PubMed Web of Science ®Google Scholar
• Brown BD, Sitia G, Annoni A, et al. in vivo administration of lentiviral vectors triggers a type I interferon response that restricts hepatocyte gene transfer and promotes vector clearance. Blood 2007;109(7):2797-805
   PubMed Web of Science ®Google Scholar
• Pichlmair A, Diebold SS, Gschmeissner S, et al. Tubulovesicular structures within vesicular stomatitis virus G protein-pseudotyped lentiviral vector preparations carry DNA and stimulate antiviral responses via Toll-like receptor 9. J Virol 2007;81(2):539-47
   PubMed Web of Science ®Google Scholar
• Follenzi A, Gupta S. The promise of lentiviral gene therapy for liver cancer J Hepatol 2004;40(2):337-40
   PubMedGoogle Scholar
• Annoni A, Battaglia M, Follenzi A, et al. The immune response to lentiviral-delivered transgene is modulated in vivo by transgene-expressing antigen-presenting cells but not by CD4+CD25+ regulatory T cells. Blood 2007;110(6):1788-96
   PubMedGoogle Scholar
• Curran MA, Kaiser SM, Achacoso PL, Nolan GP. Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors. Mol Ther 2000;1(1):31-8
   PubMed Web of Science ®Google Scholar
• Kim SS, Kothari N, You XJ, et al. Generation of replication-defective helper-free vectors based on simian immunodeficiency virus. Virology 2001;282(1):154-67
   PubMedGoogle Scholar
• Mselli-Lakhal L, Guiguen F, Greenland T, et al. Gene transfer system derived from the caprine arthritis-encephalitis lentivirus. J Virol Methods 2006;136(1-2):177-84
   PubMed Web of Science ®Google Scholar
• Poeschla E, Gilbert J, Li X, et al. Identification of a human immunodeficiency virus type 2 (HIV-2) encapsidation determinant and transduction of nondividing human cells by HIV-2-based lentivirus vectors. J Virol 1998;72(8):6527-36
   PubMed Web of Science ®Google Scholar
• Cullen BR. Regulation of HIV-1 gene expression. Faseb J 1991;5(10):2361-8
   PubMed Web of Science ®Google Scholar
• Valsamakis A, Zeichner S, Carswell S, Alwine JC. The human immunodeficiency virus type 1 polyadenylylation signal: a 3′ long terminal repeat element upstream of the AAUAAA necessary for efficient polyadenylylation. Proc Natl Acad Sci USA 1991;88(6):2108-12
   PubMed Web of Science ®Google Scholar
• Feng S, Holland EC. HIV-1 tat trans-activation requires the loop sequence within tar. Nature 1988;334(6178):165-7
   PubMed Web of Science ®Google Scholar
• Keen NJ, Gait MJ, Karn J. Human immunodeficiency virus type-1 Tat is an integral component of the activated transcription-elongation complex. Proc Natl Acad Sci USA 1996;93(6):2505-10
   PubMedGoogle Scholar
• Charneau P, Mirambeau G, Roux P, et al. HIV-1 reverse transcription. A termination step at the center of the genome. J Mol Biol 1994;241(5):651-62
   PubMed Web of Science ®Google Scholar
• Hungnes O, Tjotta E, Grinde B. Mutations in the central polypurine tract of HIV-1 result in delayed replication. Virology 1992;190(1):440-2
   PubMed Web of Science ®Google Scholar
• Schwartz S, Felber BK, Pavlakis GN. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein. J Virol 1992;66(1):150-9
   PubMedGoogle Scholar
• Rosen CA, Terwilliger E, Dayton A, et al. Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus. Proc Natl Acad Sci USA 1988;85(7):2071-5
   PubMedGoogle Scholar
• Lever A, Gottlinger H, Haseltine W, Sodroski J. Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions. J Virol 1989;63(9):4085-7
   PubMed Web of Science ®Google Scholar
• Lasky LA, Nakamura G, Smith DH, et al. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 1987;50(6):975-85
   PubMed Web of Science ®Google Scholar
• Freed EO. HIV-1 replication. Somat Cell Mol Genet. 2001;26(1-6):13-33
   PubMedGoogle Scholar
• Stein BS, Engleman EG. Intracellular processing of the gp160 HIV-1 envelope precursor. Endoproteolytic cleavage occurs in a cis or medial compartment of the Golgi complex. J Biol Chem 1990;265(5):2640-9
   PubMed Web of Science ®Google Scholar
• Chen BK, Gandhi RT, Baltimore D. CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef. J Virol 1996;70(9):6044-53
   PubMedGoogle Scholar
• Simon JH, Fouchier RA, Southerling TE, et al. The Vif and Gag proteins of human immunodeficiency virus type 1 colocalize in infected human T cells. J Virol 1997;71(7):5259-67
   PubMedGoogle Scholar
• Mann R, Baltimore D. Varying the position of a retrovirus packaging sequence results in the encapsidation of both unspliced and spliced RNAs. J Virol 1985;54(2):401-7
   PubMed Web of Science ®Google Scholar
• The Salk Institute for Biological Studies. Vector and method of use for nuleic acud delivery to non-dividing cells. WO9712622; 1997
   Google Scholar
• Delenda C. Lentiviral vectors: optimization of packaging, transduction and gene expression. J Gene Med 2004;6(Suppl 1):S125-38
   Google Scholar
• Cockrell AS, Kafri T. Gene delivery by lentivirus vectors. Mol Biotechnol 2007;36(3):184-204
   PubMed Web of Science ®Google Scholar
• Zufferey R, Nagy D, Mandel RJ, et al. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo Nat Biotechnol 1997;15(9):871-5
   PubMed Web of Science ®Google Scholar
• Dull T, Zufferey R, Kelly M, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998;72(11):8463-71
   PubMed Web of Science ®Google Scholar
• Kim VN, Mitrophanous K, Kingsman SM, Kingsman AJ. Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. J Virol 1998;72(1):811-6
   PubMedGoogle Scholar
• Naldini L, Blomer U, Gage FH, et al. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 1996;93(21):11382-8
   PubMed Web of Science ®Google Scholar
• Zufferey R, Dull T, Mandel RJ, et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 1998;72(12):9873-80
   PubMed Web of Science ®Google Scholar
• Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors. US5994136; 1999
   Google Scholar
• Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors. US6165782; 2000
   Google Scholar
• Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors. US7250299; 2007
   Google Scholar
• Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors. US6428953; 2002
   Google Scholar
• Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors. US6924144; 2005
   Google Scholar
• Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors. US7083981; 2006
   Google Scholar
• Zennou V, Petit C, Guetard D, et al. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 2000;101(2):173-85
   PubMed Web of Science ®Google Scholar
• Follenzi A, Ailles LE, Bakovic S, et al. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 2000;25(2):217-22
   PubMed Web of Science ®Google Scholar
• Institut Pasteur, Use of triplex structure DNA in transferring nucleotide sequences. US6682907; 2004
   Google Scholar
• Zufferey R, Donello JE, Trono D, Hope TJ. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 1999;73(4):2886-92
   PubMed Web of Science ®Google Scholar
• Popa I, Harris ME, Donello JE, Hope TJ. CRM1-dependent function of a cis-acting RNA export element. Mol Cell Biol 2002;22(7):2057-67
   PubMedGoogle Scholar
• The Salk Institute for Biological Studies. RNA export element. US6136597; 2000
   Google Scholar
• The Salk Institute for Biological Studies. RNA export element and methods of use. US6287814; 2001
   Google Scholar
• Oh T, Bajwa A, Jia G, Park F. Lentiviral vector design using alternative RNA export elements. Retrovirology 2007;4:38
   PubMedGoogle Scholar
• Burns JC, Friedmann T, Driever W, et al. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Nati Acad Sci USA 1993;90(17):8033-7
   PubMed Web of Science ®Google Scholar
• Naldini L, Blomer U, Gallay P, et al. in vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996;272(5259):263-7
   PubMed Web of Science ®Google Scholar
• Desmaris N, Bosch A, Salaun C, et al. Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins. Mol Ther 2001;4(2):149-56
   PubMed Web of Science ®Google Scholar
• Miletic H, Bruns M, Tsiakas K, et al. Retroviral vectors pseudotyped with lymphocytic choriomeningitis virus. J Virol 1999;73(7):6114-6
   PubMedGoogle Scholar
• Sung VM, Lai MM. Murine retroviral pseudotype virus containing hepatitis B virus large and small surface antigens confers specific tropism for primary human hepatocytes: a potential liver-specific targeting system. J Virol 2002;76(2):912-7
   PubMedGoogle Scholar
• Bartosch B, Dubuisson J, Cosset FL. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med 2003;197(5):633-42
   PubMed Web of Science ®Google Scholar
• Kobinger GP, Weiner DJ, Yu QC, Wilson JM. Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo Nat Biotechnol 2001;19(3):225-30
   PubMed Web of Science ®Google Scholar
• Spiegel M, Bitzer M, Schenk A, et al. Pseudotype formation of Moloney murine leukemia virus with Sendai virus glycoprotein F. J Virol 1998;72(6):5296-302
   PubMedGoogle Scholar
• Dong J, Roth MG, Hunter E. A chimeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range. J Virol 1992;66(12):7374-82
   PubMedGoogle Scholar
• Wool-Lewis RJ, Bates P. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J Virol 1998;72(4):3155-60
   PubMed Web of Science ®Google Scholar
• Sharkey CM, North CL, Kuhn RJ, Sanders DA. Ross River virus glycoprotein-pseudotyped retroviruses and stable cell lines for their production. J Virol 2001;75(6):2653-9
   PubMedGoogle Scholar
• Kang Y, Xie L, Tran DT, et al. Persistent expression of factor VIII in vivo following nonprimate lentiviral gene transfer. Blood 2005;106(5):1552-8
   PubMed Web of Science ®Google Scholar
• Cronin J, Zhang XY, Reiser J. Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther 2005;5(4):387-98
   PubMed Web of Science ®Google Scholar
• Aiken C. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. J Virol 1997;71(8):5871-7
   PubMed Web of Science ®Google Scholar
• Farson D, Witt R, McGuinness R, et al. A new-generation stable inducible packaging cell line for lentiviral vectors. Hum Gene Ther 2001;12(8):981-97
   PubMed Web of Science ®Google Scholar
• Croyle MA, Callahan SM, Auricchio A, et al. PEGylation of a vesicular stomatitis virus G pseudotyped lentivirus vector prevents inactivation in serum. J Virol 2004;78(2):912-21
   PubMed Web of Science ®Google Scholar
• DePolo NJ, Reed JD, Sheridan PL, et al. VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum. Mol Ther 2000;2(3):218-22
   PubMed Web of Science ®Google Scholar
• Genzyme Corporation, Polymasc Pharmaceuticals Tresyl-monomethoxypolyethylene glycol-modified viruses having viral infectivity. US6569426; 2003
   Google Scholar
• The Trustees of the University of Pennsylvania. Methods for rapid PEG-modification of viral vectors, compositions with enhanced physical stability, and uses therefore. US6399385; 2002
   Google Scholar
• Trustees of the University of the US. Rapid peg-modification of viral vectors. WO0123001; 2002
   Google Scholar
• Amado RG, Chen IS. Lentiviral vectors–the promise of gene therapy within reach? Science (New York, NY). 1999;285(5428):674-676
   PubMed Web of Science ®Google Scholar
• Segura MM, Garnier A, Durocher Y, et al. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification. Biotechnol Bioeng 2007;98(4):789-99
   PubMed Web of Science ®Google Scholar
• Segura MM, Garnier A, Kamen A. Purification and characterization of retrovirus vector particles by rate zonal ultracentrifugation. J Virol Methods 2006;133(1):82-91
   PubMedGoogle Scholar
• Pham L, Ye H, Cosset FL, et al. Concentration of viral vectors by co-precipitation with calcium phosphate. J Gene Med 2001;3(2):188-94
   PubMedGoogle Scholar
• Zhang B, Xia HQ, Cleghorn G, et al. A highly efficient and consistent method for harvesting large volumes of high-titre lentiviral vectors. Gene Ther 2001;8(22):1745-51
   PubMedGoogle Scholar
• Reiser J. Production and concentration of pseudotyped HIV-1-based gene transfer vectors. Gene Ther 2000;7(11):910-3
   PubMed Web of Science ®Google Scholar
• The Regents of the University of California. Generation, concentration and efficient transfer of VSV-G Pseudotyped Retrovral Vectors. US5512421; 1996
   Google Scholar
• Follenzi A, Naldini L. Generation of HIV-1 derived lentiviral vectors. Methods Enzymol 2002;346:454-65
   PubMed Web of Science ®Google Scholar
• Felgner PL, Gadek TR, Holm M, et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 1987;84(21):7413-7
   PubMed Web of Science ®Google Scholar
• Felgner PL, Ringold GM. Cationic liposome-mediated transfection. Nature.1989;337(6205):387-8
   PubMed Web of Science ®Google Scholar
• Zabner J, Fasbender AJ, Moninger T, et al. Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem 1995;270(32):18997-9007
   PubMed Web of Science ®Google Scholar
• Remy JS, Sirlin C, Vierling P, Behr JP. Gene transfer with a series of lipophilic DNA-binding molecules. Bioconjug Chem 1994;5(6):647-54
   PubMed Web of Science ®Google Scholar
• Leventis R, Silvius JR. Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles. Biochim Biophys Acta 1990;1023(1):124-32
   PubMed Web of Science ®Google Scholar
• Farhood H, Bottega R, Epand RM, Huang L. Effect of cationic cholesterol derivatives on gene transfer and protein kinase C activity. Biochim Biophys Acta 1992;1111(2):239-46
   PubMed Web of Science ®Google Scholar
• Behr JP, Demeneix B, Loeffler JP, Perez-Mutul J. Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. Proc Natl Acad Sci USA 1989;86(18):6982-6
   PubMed Web of Science ®Google Scholar
• Boussif O, Lezoualc'h F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Nati Acad Sci USA 1995;92(16):7297-301
   PubMed Web of Science ®Google Scholar
• Stitz J, Buchholz CJ, Engelstadter M, et al. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1. Virology 2000;273(1):16-20
   PubMed Web of Science ®Google Scholar
• Kafri T, van Praag H, Ouyang L, et al. A packaging cell line for lentivirus vectors. J Virol 1999;73(1):576-584
   PubMed Web of Science ®Google Scholar
• Klages N, Zufferey R, Trono D. A stable system for the high-titer production of multiply attenuated lentiviral vectors. Mol Ther 2000;2(2):170-6
   PubMed Web of Science ®Google Scholar
• Kumar M, Bradow BP, Zimmerberg J. Large-scale production of pseudotyped lentiviral vectors using baculovirus GP64. Hum Gene Ther 2003;14(1):67-77
   PubMed Web of Science ®Google Scholar
• Ni Y, Sun S, Oparaocha I, et al. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector. J Gene Med 2005;7(6):818-34
   PubMed Web of Science ®Google Scholar
• Pacchia AL, Adelson ME, Kaul M, et al. An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins. Virology 2001;282(1):77-86
   PubMed Web of Science ®Google Scholar
• Ausserlechner MJ, Obexer P, Deutschmann A, et al. A retroviral expression system based on tetracycline-regulated tricistronic transactivator/repressor vectors for functional analyses of antiproliferative and toxic genes. Mol Cancer Ther 2006;5(8):1927-34
   PubMedGoogle Scholar
• Ory DS, Neugeboren BA, Mulligan RC. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Nati Acad Sci USA 1996;93(21):11400-6
   PubMed Web of Science ®Google Scholar
• Yang Y, Vanin EF, Whitt MA, et al. Inducible, high-level production of infectious murine leukemia retroviral vector particles pseudotyped with vesicular stomatitis virus G envelope protein. Hum Gene Ther 1995;6(9):1203-13
   PubMed Web of Science ®Google Scholar
• Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Pro Natl Acad Sci USA 1992;89(12):5547-51
   PubMed Web of Science ®Google Scholar
• St. Judes Children's Research Hospital, Genetic Therapy, Inc. Stable virus packaging cells. US5750396; 1998
   Google Scholar
• Genetix Pharmaceuticals, Inc. Lentiviral packaging cells. US6365150; 2002
   Google Scholar
• The Salk Institute for Biological Studies. Retroviral packaging cell line. US6218181; 2001
   Google Scholar
• The Regents of the University of California. Lentiviral nucleic acids and uses thereof. US6555107; 2003
   Google Scholar
• Lung-Ji Chang. Lentiviral vectors. US6207455; 2001
   Google Scholar
• Novartis AG. Lentiviral packaging constructs. US7070993; 2006
   Google Scholar
• Lung-Ji Chang. Lentiviral vectors. US6531123; 2001
   Google Scholar
• The University of North Carolina at Chapel Hill. Lentivirus-based gene transfer vectors. US6277633; 2001
   Google Scholar
• The Children's Medical Center Corp. Packaging cells comprising codon-optimized gagpol sequences and lacking lentiviral accessory proteins. US6958226; 2005
   Google Scholar
• Schering Corporation. Methods for purifying viruses. US6261823; 2001
   Google Scholar
• Mochizuki H, Schwartz JP, Tanaka K, et al. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. J Virol 1998;72(11):8873-83
   Google Scholar
• Watson DJ, Kobinger GP, Passini MA, et al. Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins. Mol Ther 2002;5(5 Pt 1):528-37
   PubMed Web of Science ®Google Scholar
• Yamada K, McCarty DM, Madden VJ, Walsh CE. Lentivirus vector purification using anion exchange HPLC leads to improved gene transfer. Biotechniques 2003;34(5):1074-8, 80
   PubMed Web of Science ®Google Scholar
• Scherr M, Battmer K, Eder M, et al. Efficient gene transfer into the CNS by lentiviral vectors purified by anion exchange chromatography. Gene Ther 2002;9(24):1708-14
   PubMed Web of Science ®Google Scholar
• The Immune Response Corporation. Production and purification of retroviral particles using tentacle anion exchange. US5661023; 1997
   Google Scholar
• Aventis Behring GmbH. Process for separating HIV from a fluid. US6242239; 2001
   Google Scholar
• Canji, Inc. Method of purification of viral vectors. US5837520; 1998
   Google Scholar
• Finnegan, Henderson, Farabow, Garrett, and Dunner, L.L.P. Method for producing recombinant adenovirus. US6485958; 2002
   Google Scholar
• Genetic Therapy, Inc. Purification of retroviral vectors. US5661022; 1997
   Google Scholar
• Sepracor Inc. Passivated and stabilized porous mineral oxide supports and method for the preparation and use of the same. US5268097; 1993
   Google Scholar
• Richieri SP, Bartholomew R, Aloia RC, et al. Characterization of highly purified, inactivated HIV-1 particles isolated by anion exchange chromatography. Vaccine 1998;16(2-3):119-29
   PubMed Web of Science ®Google Scholar
• Scherr M, Battmer K, Blomer U, et al. Lentiviral gene transfer into peripheral blood-derived CD34+ NOD/SCID-repopulating cells. Blood 2002;99(2):709-12
   PubMed Web of Science ®Google Scholar
• Slepushkin V, Chang N, Cohen R, et al. Large-scale purification of lentiviral vector by size exclusion chromatography or Mustang Q ion exchange capsule. BioProcess J 2003;89-95
   Google Scholar
• MacGregor RR. Clinical protocol. A phase 1 open-label clinical trial of the safety and tolerability of single escalating doses of autologous CD4 T cells transduced with VRX496 in HIV-positive subjects. Hum Gene Ther 2001;12(16):2028-9
   PubMedGoogle Scholar
• Levine BL, Humeau LM, Boyer J, et al. Gene transfer in humans using a conditionally replicating lentiviral vector. Proc Natl Acad Sci USA 2006;103(46):17372-7
   PubMed Web of Science ®Google Scholar
• Scherr M, Battmer K, Blomer U, et al. Quantitative determination of lentiviral vector particle numbers by real-time PCR. Biotechniques 2001;31(3):520 2, 4, passim
   PubMedGoogle Scholar
• Lizee G, Aerts JL, Gonzales MI, et al. Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression. Hum Gene Ther 2003;14(6):497-507
   PubMedGoogle Scholar
• Blomer U, Naldini L, Kafri T, et al. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J Virol 1997;71(9):6641-9
   PubMed Web of Science ®Google Scholar
• Ralph GS, Binley K, Wong LF, et al. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors. Clin Sci (Lond) 2006;110(1):37-46
   PubMed Web of Science ®Google Scholar
• Wong LF, Goodhead L, Prat C, et al. Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications. Hum Gene Ther 2006;17(1):1-9
   PubMed Web of Science ®Google Scholar
• Oxford Biomedia (UK) Limited. Lentiviral LTR-deleted vector. US7056699; 2006
   Google Scholar
• Arch Development Corporation. Vesicular monoamine transporter gene therapy in parkinson's disease. US7115258; 2006
   Google Scholar
• The United States of America as represented by the Department of Health and Human Services. Molecular clones with mutated HIV gag/pol, SIV gag and SIV
   Google Scholar
• Miyoshi H, Takahashi M, Gage FH, Verma IM. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci USA 1997;94(19):10319-23
   PubMed Web of Science ®Google Scholar
• Bemelmans AP, Kostic C, Crippa SV, et al. Lentiviral gene transfer of RPE65 rescues survival and function of cones in a mouse model of Leber congenital amaurosis. PLoS Med 2006;3(10):e347
   PubMed Web of Science ®Google Scholar
• Tschernutter M, Schlichtenbrede FC, Howe S, et al. Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy. Gene Ther 2005;12(8):694-701
   PubMedGoogle Scholar
• Yanez-Munoz RJ, Balaggan KS, MacNeil A, et al. Effective gene therapy with nonintegrating lentiviral vectors. Nat med 2006;12(3):348-53
   PubMed Web of Science ®Google Scholar
• Bainbridge JW, Tan MH, Ali RR. Gene therapy progress and prospects: the eye. Gene Ther 2006;13(16):1191-7
   PubMed Web of Science ®Google Scholar
• Miyoshi H, Smith KA, Mosier DE, et al. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 1999;283(5402):682-6
   PubMed Web of Science ®Google Scholar
• May C, Rivella S, Callegari J, et al. Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin. Nature 2000;406(6791):82-6
   PubMed Web of Science ®Google Scholar
• Pawliuk R, Westerman KA, Fabry ME, et al. Correction of sickle cell disease in transgenic mouse models by gene therapy. Science 2001;294(5550):2368-71
   PubMed Web of Science ®Google Scholar
• Hofling AA, Devine S, Vogler C, Sands MS. Human CD34+ hematopoietic progenitor cell-directed lentiviral-mediated gene therapy in a xenotransplantation model of lysosomal storage disease. Mol Ther 2004;9(6):856-65
   PubMed Web of Science ®Google Scholar
• Human Gene Transfer Protocols. Available from: http://www4.od.nih.gov/oba/rac/protocol.pdf
   Google Scholar
• Picanco-Castro V, Russo-Carbolante EM, Fontes AM, et al. An enhancer/promoter combination strengthens the expression of blood-coagulation factor VIII in non-viral expression vectors. Genet Mol Res In press
   Google Scholar
• Humeau LM, Binder GK, Lu X, et al. Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load. Mol Ther 2004;9(6):902-13
   PubMed Web of Science ®Google Scholar
• Manilla P, Rebello T, Afable C, et al. Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector. Hum Gene Ther 2005;16(1):17-25
   PubMed Web of Science ®Google Scholar
• Cohen J. Building an HIV-proof immune system. Science (New York, NY) 2007;317(5838):612-4
   PubMedGoogle Scholar
• Kohn DB. Lentiviral vectors ready for prime-time. Nat Biotechnol 2007;25(1):65-6
   PubMed Web of Science ®Google Scholar
• Virxsys Corporation. Regulated nucleic acid expression system. US6835568; 2004
   Google Scholar
• VIRxSYS Corporation. Methods for stable transduction of cells with HIV-derived viral vectors. US6627442l; 2003
   Google Scholar
• Park F, Ohashi K, Kay MA. Therapeutic levels of human factor VIII and IX using HIV-1-based lentiviral vectors in mouse liver. Blood 2000;96(3):1173-6
   PubMed Web of Science ®Google Scholar
• Park F, Ohashi K, Kay MA. The effect of age on hepatic gene transfer with self-inactivating lentiviral vectors in vivo Mol Ther 2003;8(2):314-23
   PubMedGoogle Scholar
• Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003;302(5644):415-9
   PubMed Web of Science ®Google Scholar
• Jacoby J. Gene therapy introduces a new series of interviews. Gene Ther 2005;12(12):949
   PubMedGoogle Scholar
• Lu X, Humeau L, Slepushkin V, et al. Safe two-plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one-step protocol. J Gene Med 2004;6(9):963-73
   PubMed Web of Science ®Google Scholar